This week, our guests are Viktoriya Vasilenko, Knowledge Gate co-founder and CEO; and Avery Ince, vice president, medical affairs, cardiovascular & metabolism at Janssen Scientific Affairs.
Study confirms benefit of XARELTO (rivaroxaban) for secondary prevention of venous…
Source: www.labiotech.eu – Read more



